Xiamen Amoytop Biotech Co., Ltd. is a leading manufacturer of recombinant bio-pharmaceutical products in China, operating under cGMP (current Good Manufacturing Practice) standards. The company produces a range of biologics, including Molgramostim, Filgrastim, Oprelvekin, and Peginterferon alfa 2b, which are marketed domestically and exported to various countries. In addition to its pharmaceutical offerings, Xiamen Amoytop supplies bio-reagents for laboratory and research applications, such as Interleukin-4, TNF-alfa, IFN-gamma, IL-15, and SCF. Furthermore, the company is at the forefront of developing innovative drug delivery technologies, including their Y-shaped branch PEG Drug Delivery Technology for Pegfilgrastim, Pegsomatropin, and Peg-EPO. As the first and largest company to launch domestic Molgramostim in China, Xiamen Amoytop serves as a reference standard supplier to national institutes.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Biologics
- Contract Manufacturing (CMO/CDMO)
- Contract Research Organisation (CRO)
- Contract Services
- Consumer Goods
- Distributor

Xiamen Amoytop Biotech Co., Ltd. is dedicated to advancing biopharmaceutical research and production, ensuring high-quality products and services that meet the needs of the pharmaceutical industry. For more information, please visit amoytop.com.